SAH GLOBAL DEVELOPING VISONS
SAH Global manages highly specialized investment projects within a variety of sectors, including communications, healthcare, energy and real estate. We target investment projects based on their long-term growth prospects, their use of cutting-edge technologies and their potential impact on the community as a whole.
There is a rapid increase of new cancer cases in Saudi Arabia, United Arab Emirates, Qatar, Oman, Kuwait, Bahrain and elsewhere in the Middle-East and North Africa, however, few have access to the treatment because of its limited availability. For a decade, going through the long and complex process of designing, building, and operating its own PET and Proton Therapy centers, SAH has thoroughly consulted numerous physicists, chemists, oncologists, pharmacists, biologists, engineers, technicians, manufacturers, architects, and specialists of nuclear medicine, radioprotection, safety, quality and more, to select the best options. Our team has gathered unparalleled experience in Designing, Building and Operating PET and Proton Therapy Centers.
PET & Molecular Imaging
SAH Global Partners with VisionTree to Improve Patient Outcomes Through Its Innovative Cloud Based Solution
SAH Inks Agreement to Distribute VisionTree® Software Throughout Middle East Region and the EU Riyadh, Saudi Arabia – 16th May 2016 Proton Therapy Pioneers SAH Global announced today at Saudi Health 2016, that they have signed a Collaboration and Exclusive...read more
SAH Global, a leader in establishing a network of Proton Therapy and Molecular Imaging Centers in the MENA region, exhibited their turnkey solutions at Arab Health and hosted the following workshops, including the first ever workshop on Proton Therapy to be held at...read more
Muscat, Oman – 1st October, 2015 – The Research Council of Oman signed today a Letter of Intent (LOI) with SAH Global to develop its SAH Oman PET & Proton center at the Innovation Park Muscat. (IPM). This represents the first Healthcare company the IPM has...read more